ACTRAPID

This brand name is authorized in Austria, Australia, Cyprus, Germany, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, South Africa

Active ingredients

The drug ACTRAPID contains one active pharmaceutical ingredient (API):

1 Insulin human biosynthetic UNII 1Y17CTI5SR - INSULIN HUMAN

The blood glucose lowering effect of insulin is due to the facilitated uptake of glucose following binding of insulin to receptors on muscle and fat cells and to the simultaneous inhibition of glucose output from the liver. Read about Insulin (human)

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ACTRAPID Solution for injection	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A10AB01	Insulin (human)	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10A Insulins and analogues → A10AB Insulins and analogues for injection, fast-acting
Discover more medicines within A10AB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 1531N, 1762R
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00145589, 00145603, 00536338, 00536427, 00536692, 00536700, 00536752, 00536775, 02949004, 03029665, 03366279, 03647328, 03647334, 03743173, 03743210, 04091399, 04091407, 04245916, 04245922, 04393692, 04393717, 04405780, 04405797, 06135913, 06306958, 07653283, 10739663, 13711808, 14218524, 15861357, 16582056
Country: EE	Ravimiamet	Identifier(s): 1006355, 1011463, 1215740, 1215751, 1215773, 1215784, 1215795, 1215807, 1215818, 1318137, 1318148, 1318159, 1318160
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 02230003, 02230011
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 013509
Country: FR	Base de données publique des médicaments	Identifier(s): 61995884, 62809126
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 33122
Country: HK	Department of Health Drug Office	Identifier(s): 25781, 60290, 63758, 66078
Country: IE	Health Products Regulatory Authority	Identifier(s): 62006
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 2862, 646
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1004376, 1008808, 1015618, 1015622, 1027228, 1027229, 1027231, 1027232, 1027233, 1027234, 1027235, 1027236, 1027237, 1027238, 1027239, 1027240, 1027241
Country: NL	Z-Index G-Standaard	Identifier(s): 14816032, 14816040, 14816059
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 97314, 97322, 97330
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 10728, 3501, 3519
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100031049, 100103180, 100308485, 100308491, 100308500
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W03621002, W03621003, W10503001, W10503002, W10503003, W13933001, W13933002, W13933003, W52539001, W52539002, W52539003, W52540001, W52540002, W52540003, W52541001, W52541002, W52541003
Country: SG	Health Sciences Authority	Identifier(s): 02395P, 02397P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 5993016, 5993024
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699676770496, 8699676950348
Country: ZA	Health Products Regulatory Authority	Identifier(s): W/21.1/288